|
|
|
|
|
|
|
|
|
|
Commercial International Bank (Egypt) S.A.E. |
||||
Consolidated Financial Statements |
||||
September 30, 2021 |
||||
|
|
|
|
|
|
|
|
|
|
Click on, or paste the following link into your web browser, to view the associated PDF document.http://www.rns-pdf.londonstockexchange.com/rns/1594S_1-2021-11-11.pdf
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Interim Cash flows for the period ended September 30, 2021 |
||||
|
|
|
|
|
|
Notes |
Sep. 30, 2021 |
|
Sep. 30, 2020 |
|
|
EGP Thousands |
|
EGP Thousands |
|
|
|
|
|
Cash flow from operating activities |
|
|
|
|
Profit before income tax from continued operations |
|
13,979,431 |
|
11,239,451 |
Adjustments to reconcile net profit to net cash provided by operating activities |
|
|
|
|
Fixed assets depreciation |
14 |
636,413 |
|
558,536 |
Impairment charge for credit losses (Loans and advances to customers and banks) |
|
1,383,887 |
|
3,761,456 |
Other provisions charges |
18 |
190,525 |
|
974,522 |
Impairment charge for credit losses (due from banks) |
|
37,880 |
|
13,218 |
Impairment (Released) charge for credit losses (financial investments) |
|
(98,246) |
|
88,192 |
Impairment (Released) charge for other assets |
|
31,975 |
|
56,245 |
Exchange revaluation differences for financial assets at fair value through OCI |
|
40,050 |
|
238,906 |
Goodwill amortization |
23 |
58,448 |
|
20,302 |
Intangible assets amortization |
24 |
14,685 |
|
- |
Impairment (Released) charge financial assets at fair value through OCI |
|
- |
|
79,126 |
Utilization of other provisions |
18 |
(44,978) |
|
(1,479) |
Other provisions no longer used |
18 |
(12,255) |
|
(6,022) |
Exchange differences of other provisions |
18 |
(13,722) |
|
(17,670) |
Profits from selling property and equipment |
|
(2,124) |
|
(872) |
Losses (profits) from selling financial investments |
12 |
(643,467) |
|
(979,144) |
Impairment (Released) charges of investments in associates and subsidiaries |
|
(15,016) |
|
14,100 |
Shares based payments |
|
477,644 |
|
447,694 |
Bank's share in the profits of associates |
|
(18,354) |
|
(24,327) |
Operating losses (profits) before changes in operating assets and liabilities |
|
16,002,776 |
|
16,462,234 |
|
|
|
|
|
Net decrease (increase) in assets and liabilities |
|
|
|
|
Due from banks |
|
(272,238) |
|
(5,972,551) |
Financial assets at fair value through P&L |
12 |
153,260 |
|
74,562 |
Derivative financial instruments |
|
(24,448) |
|
(3,735) |
Loans and advances to banks and customers |
10 - 11 |
(20,943,748) |
|
(2,977,814) |
Other assets |
|
(1,611,672) |
|
592,680 |
Due to banks |
15 |
(7,271,485) |
|
(2,990,512) |
Due to customers |
16 |
63,033,657 |
|
27,878,364 |
Income tax obligations paid |
|
(2,153,441) |
|
(4,389,254) |
Other liabilities |
|
1,706,495 |
|
(4,589,999) |
Net cash used in (generated from) operating activities |
|
48,619,156 |
|
24,083,975 |
|
|
|
|
|
Cash flow from investing activities |
|
|
|
|
Proceeds from Investments in associates. |
|
- |
|
750 |
Proceeds (payments) for investment in associates. |
|
(158,360) |
|
- |
Payment for purchases of property, equipment and branches constructions |
|
(677,464) |
|
(921,312) |
Proceeds from selling property and equipment |
|
2,124 |
|
872 |
Proceeds from redemption of financial assets at amortized cost |
|
4,753,398 |
|
37,493,345 |
Payment for purchases of financial assets at amortized cost |
|
(2,617) |
|
- |
Payment for purchases of financial assets at fair value through OCI |
|
(208,509,917) |
|
(55,823,590) |
Proceeds from selling financial assets at fair value through OCI |
|
147,101,717 |
|
24,041,845 |
Proceeds from investment in subsidiaries. |
|
- |
|
194,722 |
Net cash generated from (used in) investing activities |
|
(57,491,119) |
|
4,986,632 |
|
|
|
|
|
|
|
|
|
|
|
||||
Condensed Consolidated Interim Cash flows for the period ended September 30, 2021 (Cont.) |
||||
|
|
|
|
|
|
|
Sep. 30, 2021 |
|
Sep. 30, 2020 |
|
|
EGP Thousands |
|
EGP Thousands |
|
|
|
|
|
Cash flow from financing activities |
|
|
|
|
Received (Repaid) in long term loans |
|
(2,113,845) |
|
4,492,249 |
Dividend paid |
|
(1,360,652) |
|
(3,370,464) |
Issued debt instruments |
|
1,556,032 |
|
- |
Capital increase |
|
- |
|
85,992 |
Net cash generated from (used in) financing activities |
|
(1,918,465) |
|
1,207,777 |
|
|
|
|
|
|
|
|
|
|
Net (decrease) increase in cash and cash equivalent during the period |
|
(10,790,428) |
|
30,278,384 |
Beginning balance of cash and cash equivalent |
|
75,796,375 |
|
22,895,017 |
Cash and cash equivalent at the end of the period |
|
65,005,947 |
|
53,173,401 |
|
|
|
|
|
Cash and cash equivalent comprise: |
|
|
|
|
Cash and balances at the central bank |
|
33,326,348 |
|
35,786,423 |
Due from banks |
|
72,296,624 |
|
56,934,238 |
Treasury bills and other governmental notes |
9 |
65,656,846 |
|
32,133,958 |
Obligatory reserve balance with CBE |
|
(27,265,818) |
|
(30,004,955) |
Due from banks with maturities more than three months |
|
(16,980,376) |
|
(8,958,909) |
Treasury bills with maturity more than three months |
|
(62,027,677) |
|
(32,717,354) |
Total cash and cash equivalent |
|
65,005,947 |
|
53,173,401 |
'
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Interim statement of changes in shareholders' equity for the period ended September 30, 2020 |
|
|
|
|
|||||||||||
Sep. 30, 2020 |
Issued and paid up capital |
Legal reserve |
General reserve |
General risk reserve |
Reserve for transactions under common control |
Capital reserve |
Reserve for financial assets at fair value through OCI |
Banking risks reserve |
Retained earnings |
Reserve for employee stock ownership plan |
Cumulative foreign currencies translation differences |
Total Shareholders Equity |
Minority Interest |
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EGP Thousands |
|
Beginning balance |
14,690,821 |
2,188,029 |
16,474,429 |
1,549,445 |
- |
13,466 |
4,111,781 |
5,164 |
11,881,657 |
963,152 |
2,501 |
51,880,445 |
- |
51,880,445 |
|
Capital increase |
85,992 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
85,992 |
- |
85,992 |
|
Transferred to reserves |
- |
590,106 |
7,840,287 |
- |
- |
1,440 |
- |
- |
(8,431,833) |
- |
- |
- |
- |
- |
|
Dividend paid |
- |
- |
- |
- |
- |
- |
- |
- |
(3,370,464) |
- |
- |
(3,370,464) |
- |
(3,370,464) |
|
Minority interest |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
343,954 |
343,954 |
|
Net profit of the period |
- |
- |
- |
- |
- |
- |
- |
- |
7,346,392 |
- |
- |
7,346,392 |
(2,100) |
7,344,292 |
|
Transferred from reserve of financial assets at fair value through OCI |
- |
- |
- |
- |
- |
- |
(76,717) |
- |
76,717 |
- |
- |
- |
- |
- |
|
Net unrealised gain/(loss) on financial assets at fair value through OCI |
- |
- |
- |
- |
- |
- |
(2,292,039) |
- |
- |
- |
- |
(2,292,039) |
- |
(2,292,039) |
|
Transferred (from) to banking risk reserve |
- |
- |
- |
- |
- |
- |
- |
1,259 |
(1,259) |
- |
- |
- |
- |
- |
|
ECL for impairment of debt instruments investments |
- |
- |
- |
- |
- |
- |
88,192 |
- |
- |
- |
- |
88,192 |
- |
88,192 |
|
Cost of employees stock ownership plan (ESOP) |
- |
- |
- |
- |
- |
- |
- |
- |
- |
447,694 |
- |
447,694 |
- |
447,694 |
|
Cumulative foreign currencies translation differences |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
(1,187) |
(1,187) |
- |
(1,187) |
|
Balance at the end of the period |
14,776,813 |
2,778,135 |
24,314,716 |
1,549,445 |
- |
14,906 |
1,831,217 |
6,423 |
7,501,210 |
1,410,846 |
1,314 |
54,185,025 |
341,854 |
54,526,879 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Interim statement of changes in shareholders' equity for the period ended September 30, 2021 |
|
|
|
|
|||||||||||
Sep. 30, 2021 |
Issued and paid up capital |
Legal reserve |
General reserve |
General risk reserve |
Reserve for transactions under common control |
Capital reserve |
Reserve for financial assets at fair value through OCI |
Banking risks reserve |
Retained earnings |
Reserve for employee stock ownership plan |
Cumulative foreign currencies translation differences |
Total Shareholders Equity |
Minority Interest |
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EGP Thousands |
|
Beginning balance |
14,776,813 |
2,778,135 |
24,765,658 |
1,549,445 |
8,183 |
14,906 |
3,975,514 |
6,423 |
10,539,715 |
1,064,648 |
(3,684) |
59,475,756 |
483,055 |
59,958,811 |
|
Capital increase |
4,925,605 |
- |
(4,925,605) |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
Transferred to reserves |
- |
514,939 |
8,420,479 |
1,461 |
- |
1,094 |
- |
- |
(8,937,973) |
- |
- |
- |
- |
- |
|
Dividend paid |
- |
- |
- |
- |
- |
- |
- |
- |
(1,360,652) |
- |
- |
(1,360,652) |
- |
(1,360,652) |
|
Minority Interest share |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
(25,219) |
(25,219) |
|
Net profit of the period
|
- |
- |
- |
- |
- |
- |
- |
- |
9,877,295 |
- |
- |
9,877,295 |
(1,932) |
9,875,363 |
|
Transferred from reserve on disposal of financial assets at fair value through OCI |
- |
- |
- |
- |
- |
- |
(177,362) |
- |
177,362 |
- |
- |
- |
- |
- |
|
Transferred from previous years' outstanding balances |
- |
- |
- |
- |
- |
- |
- |
- |
8,333 |
- |
- |
8,333 |
- |
8,333 |
|
Net unrealised gain/(loss) on financial assets at fair value through OCI |
- |
- |
- |
- |
- |
- |
(2,375,618) |
- |
- |
- |
- |
(2,375,618) |
- |
(2,375,618) |
|
Transferred (from) to banking risk reserve |
- |
- |
- |
- |
- |
- |
- |
2,718 |
(2,718) |
- |
- |
- |
- |
- |
|
Effect of ECL in fair value of debt instruments measured at fair value through OCI |
- |
- |
- |
- |
- |
- |
(98,246) |
- |
- |
- |
- |
(98,246) |
- |
(98,246) |
|
Cost of employees stock ownership plan (ESOP) |
- |
- |
- |
- |
- |
- |
- |
- |
- |
477,644 |
- |
477,644 |
- |
477,644 |
|
Cumulative foreign currencies translation differences |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
1,048 |
1,048 |
- |
1,048 |
|
Balance at the end of the period |
19,702,418 |
3,293,074 |
28,260,532 |
1,550,906 |
8,183 |
16,000 |
1,324,288 |
9,141 |
10,301,362 |
1,542,292 |
(2,636) |
66,005,560 |
455,904 |
66,461,464 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|